Mirtazapine may have the propensity for developing a restless legs syndrome? A case report

被引：30

作者：

Bahk, WM ^{[1
]}

Pae, CU ^{[1
]}

Chae, JH ^{[1
]}

Jun, TY ^{[1
]}

Kim, KS ^{[1
]}

机构：

[1] Catholic Univ Korea, Coll Med, St Marys Hosp, Dept Psychiat, Seoul, South Korea

来源：

PSYCHIATRY AND CLINICAL NEUROSCIENCES | 2002年 / 56卷 / 02期

关键词：

D O I：

10.1046/j.1440-1819.2002.00955.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：209 / 210

页数：2

共 11 条

[1] Fluoxetine and restless legs syndrome [J].

Bakshi, R .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 142 (1-2) :151-152

[2]

Bonin B, 2000, THERAPIE, V55, P655

[3] Restless leg syndrome exacerbated by sertraline [J].

Hargrave, R ;

Beckley, DJ .

PSYCHOSOMATICS, 1998, 39 (02) :177-178

[4] Mianserin and restless legs [J].

Markkula, J ;

Lauerma, H .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (01) :53-58

[5] Mirtazapine: Pharmacology in relation to adverse effects [J].

Nutt, D .

ACTA PSYCHIATRICA SCANDINAVICA, 1997, 96 :31-37

[6] MIANSERIN-INDUCED RESTLESS LEGS SYNDROME [J].

PAIK, IH ;

CHUL, L ;

CHOI, BM ;

CHAE, YL ;

KIM, CE .

BRITISH JOURNAL OF PSYCHIATRY, 1989, 155 :415-417

[7] BENEFICIAL EFFECT OF LOW-DOSE MIANSERIN ON FLUVOXAMINE-INDUCED AKATHISIA IN AN OBSESSIVE-COMPULSIVE PATIENT [J].

POYUROVSKY, M ;

MEEROVICH, I ;

WEIZMAN, A .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (02) :111-114

[8] Restless legs syndrome and paroxetine [J].

SanzFuentenebro, FJ ;

Huidobro, A ;

TejadasRivas, A .

ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (06) :482-484

[9] Restless legs syndrome: Clinical features and treatment [J].

Tan, EK ;

Ondo, W .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (06) :397-403

[10] Clinical pharmacokinetics of mirtazapine [J].

Timmer, CJ ;

Sitsen, JMA ;

Delbressine, LP .

CLINICAL PHARMACOKINETICS, 2000, 38 (06) :461-474

← 1 2 →